Quantcast
Last updated on April 16, 2014 at 17:34 EDT

Latest BioNTech AG Stories

2013-07-04 04:21:46

MAINZ, Germany, July 4, 2013 /PRNewswire/ -- Glioma Actively Personalized Vaccine Consortium (GAPVAC): 14 organizations in Europe and the US join forces to develop a completely novel approach to fight cancer Multi-national clinical trial treating glioblastoma patients with fully personalized therapeutic vaccines planned to start in 2014 European Union supports GAPVAC with 6 million EUR A highly innovative...

2012-10-30 03:20:41

MAINZ, Germany, October 30, 2012 /PRNewswire/ -- BioNTech AG, a pharmaceutical company based in Mainz, reports that it has successfully expanded its management team with the appointment of Sean Marett as COO. Sean Marett has over 25 years' experience in the management of operations, licensing, M&A and new product development spanning from large pharmaceutical companies such as GSK and UCB to contract research, development and manufacturing companies such as Evotec...

2012-01-17 08:44:00

MAINZ, Germany, January 17, 2012 /PRNewswire/ -- The Institute of Translational Oncology (TRON) together with BioNTech AG today announced the publication of a joint paper in the international journal Cancer Research that describes a new path for individually tailored cancer therapy. An interdisciplinary team of genome scientists and immunologists led by the cancer researcher Prof. Ugur Sahin for the first time demonstrated that whole cancer genome information could be used to...